What can the presence of round epithelial cells on a urinalysis indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Round Epithelial Cells on Urinalysis: Clinical Significance

Round epithelial cells on urinalysis most commonly represent renal tubular epithelial cells (RTECs), which indicate tubular injury and can signal upper urinary tract pathology, kidney disease progression, or acute kidney injury—making them a critical marker that should prompt further evaluation of renal function and consideration of upper tract disease.

Primary Clinical Implications

Renal Tubular Injury and Disease Severity

Round epithelial cells, specifically RTECs, serve as markers of tubular damage and correlate with disease severity:

  • Chronic Kidney Disease (CKD): The presence and quantity of RTECs correlate with CKD severity. Patients with more round cells are significantly more likely to require hemodialysis within one year 1. In end-stage renal failure patients, these cells appear with greater frequency and their numbers directly correlate with disease progression 1.

  • Diabetic Nephropathy: RTECs or RTEC casts in urine sediment indicate more severe kidney injury. Patients with these findings demonstrate significantly higher proteinuria (6.0 vs 3.6 g/24h), higher serum creatinine (227.9 vs 177.0 μmol/L), and lower eGFR (25.8 vs 35.7 mL/min/1.73m²) 2. The presence of RTECs is independently associated with progression to end-stage kidney disease (HR 1.670,95% CI 1.042-2.676) 2.

Upper vs. Lower Urinary Tract Differentiation

RTECs are particularly valuable for distinguishing upper from lower urinary tract pathology:

  • RTECs demonstrate acceptable diagnostic performance for upper UTI diagnosis 3
  • Their presence helps differentiate pyelonephritis from cystitis
  • Unlike transitional epithelial cells (TECs), which lack diagnostic utility for upper tract disease, RTECs add meaningful clinical value 3

Acute Kidney Injury

In acute renal failure, nephrologist-performed urinalysis identifying RTECs achieved 92.3% diagnostic accuracy compared to only 19-23% accuracy when clinical laboratories failed to properly identify these cells 4. This dramatic difference stems from laboratories frequently misidentifying RTECs as squamous epithelial cells 4.

Adaptive State and Prognosis

Recent single-cell profiling reveals that urinary tubular epithelial cells in diabetic kidney disease exist in adaptive states (aTECs) 5:

  • Early DKD: Higher ratio of aTECs in progenitor and fibrosis states
  • Prognostic value: The ratio of progenitor/proliferative aTECs to fibrosis aTECs provides diagnostic information about tubular injury state
  • These cells represent early derivatives of injured proximal tubules and can indicate disease trajectory 5

Critical Diagnostic Pitfalls

Laboratory Misidentification

The most significant pitfall is laboratory misclassification of RTECs as squamous epithelial cells 4. This occurs because:

  • Clinical laboratory technologists may lack training in RTEC identification
  • RTECs can appear morphologically similar to squamous cells to untrained observers
  • Automated analyzers may not distinguish these cell types with sufficient accuracy

When to Suspect Upper Tract Disease

Consider upper urinary tract pathology when RTECs are present with:

  • Fever, flank pain, or costovertebral angle tenderness
  • Elevated inflammatory markers
  • Hematuria (particularly microscopic hematuria, the most common presentation of bladder cancer) 6, 7
  • Positive urine cytology with normal cystoscopy (requires upper tract evaluation) 7

Actionable Clinical Algorithm

When round epithelial cells (RTECs) are identified:

  1. Assess renal function immediately: Check serum creatinine, eGFR, and proteinuria
  2. Determine location of pathology:
    • With fever/flank pain → Image upper tracts (CT urogram preferred if contrast safe) 7
    • With isolated microscopic hematuria → Cystoscopy and upper tract imaging 6, 7
    • With declining renal function → Consider nephrology referral
  3. Quantify severity: Higher RTEC counts correlate with worse prognosis and may predict need for dialysis within one year 1, 2
  4. Monitor progression: Serial urinalysis with RTEC quantification can track disease trajectory

Distinction from Other Epithelial Cells

  • Squamous epithelial cells: Indicate contamination/colonization (cutoffs: >21.35/µL in women, >5.05/µL in men) 8
  • Transitional epithelial cells: Originate from bladder/ureters but lack diagnostic value for upper UTI 3
  • RTECs: Specifically indicate tubular injury and upper tract pathology

The presence of RTECs should never be dismissed as benign contamination—they represent active kidney injury requiring investigation and potentially urgent intervention.

References

Research

Novel round cells in urine sediment and their clinical implications.

Clinica chimica acta; international journal of clinical chemistry, 2016

Research

Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005

Guideline

bladder cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

bladder cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.